+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Brain Cancer Drugs Market Research Reports

Ependymoma - Pipeline Insight, 2025 - Product Thumbnail Image

Ependymoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Malignant Glioma - Pipeline Insight, 2025 - Product Thumbnail Image

Malignant Glioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Brain Metastasis - Pipeline Insight, 2025 - Product Thumbnail Image

Brain Metastasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Recurrent Malignant Glioma - Pipeline Insight, 2025 - Product Thumbnail Image

Recurrent Malignant Glioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Glioblastoma Multiforme (GBM) - Pipeline Insight, 2025 - Product Thumbnail Image

Glioblastoma Multiforme (GBM) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pediatric Neuroblastoma - Pipeline Insight, 2025 - Product Thumbnail Image

Pediatric Neuroblastoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Brain Tumor Drugs Market Report 2025 - Product Thumbnail Image

Brain Tumor Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Adult Malignant Glioma Therapeutics Market Report 2025 - Product Thumbnail Image

Adult Malignant Glioma Therapeutics Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Glioblastoma Multiforme (GBM) Treatment Market Report 2025 - Product Thumbnail Image

Glioblastoma Multiforme (GBM) Treatment Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Glioma Treatment Market Report 2025 - Product Thumbnail Image

Glioma Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Pediatric Neuroblastoma Treatment Market Report 2025 - Product Thumbnail Image

Pediatric Neuroblastoma Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Low-Grade Glioma Global Market Report 2025 - Product Thumbnail Image

Low-Grade Glioma Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Gliosarcoma Global Market Report 2025 - Product Thumbnail Image

Gliosarcoma Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Glioblastoma Multiforme Global Market Report 2025 - Product Thumbnail Image

Glioblastoma Multiforme Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
Malignant Glioma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Malignant Glioma Therapeutics - Global Strategic Business Report

  • Report
  • December 2025
  • 383 Pages
  • Global
From
Methotrexate Drugs - Global Strategic Business Report - Product Thumbnail Image

Methotrexate Drugs - Global Strategic Business Report

  • Report
  • December 2025
  • 564 Pages
  • Global
From
Neuroblastoma Drugs - Global Strategic Business Report - Product Thumbnail Image

Neuroblastoma Drugs - Global Strategic Business Report

  • Report
  • December 2025
  • 263 Pages
  • Global
From
Glioma Treatment - Global Strategic Business Report - Product Thumbnail Image

Glioma Treatment - Global Strategic Business Report

  • Report
  • December 2025
  • 179 Pages
  • Global
From
Loading Indicator

The Brain Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat brain cancer. Brain cancer is a type of cancer that affects the cells of the brain and can be caused by a variety of factors, including genetics, environmental exposure, and lifestyle. Brain cancer drugs are used to treat the symptoms of brain cancer, such as headaches, seizures, and nausea, as well as to slow the progression of the disease. Brain cancer drugs are typically divided into two categories: chemotherapy and targeted therapy. Chemotherapy drugs are used to kill cancer cells, while targeted therapy drugs are designed to target specific cancer cells and stop them from growing. Both types of drugs are used in combination to treat brain cancer. Some of the major companies in the Brain Cancer Drugs market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. These companies are involved in the development and sale of drugs used to treat brain cancer, as well as in the research and development of new treatments. Show Less Read more